Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
An Australian Phase I trial in 17 healthy volunteers showed that THVD-201 was safe and improved salivary output and related dry mouth side effects compared to Detrol LA tolterodine from Pfizer Inc. ...